Concordia Pharmaceuticals Inc. – FDA Inspection, Sep 27, 2017

Record Details

This FDA Inspection record concerns Concordia Pharmaceuticals Inc., with an inspection on September 27, 2017, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Concordia Pharmaceuticals Inc.
Inspection Date: September 27, 2017
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Hala L. Selby (Issuing Officer)

View Company Profile

ID · 240dfa95-062a-43ae-a686-539365b46f50

Inspection Facts

Inspection number: 1029145
FDA center: Human Drugs
Project area: Postmarket Surv. and Epidemiology
Outcome: Form 483 issued

FDA Citations

21 CFR 314.80(c)(1)(i)Late submission of 15-day report

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Concordia Pharmaceuticals Inc.

FDA Inspection

Concordia Pharmaceuticals Inc.September 27, 2017